A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine ...
COVID-19 mRNA vaccines significantly increased survival times in patients with advanced lung and skin cancer undergoing ...
A study published in The Lancet Child & Adolescent Health looks at myocarditis and vascular and inflammatory diseases after COVID-19 infection and vaccination in children. Prof Saidi (Sam) Mohiddin, ...
The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...
Pfizer (PFE) stock is in focus as the company exceeds Street forecasts with its Q3 2025 results thanks mainly to its COVID ...
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.
The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.
CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they ...
Researchers found that lung and skin cancer patients who got COVID-19 vaccines reported significantly increased survival ...
Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...
The new Moderna COVID vaccine, mNexspike, is approved for adults 65 and older and people 12 to 64 with an underlying medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback